Research Article
Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study
Table 4
BMI and tumor histopathologic features in postmenopausal Colombian breast cancer patients.
| | Tumor characteristics | BMI | | Normal | Overweight | Obese | value |
| | Lymph nodes , (%) | | | | | | Nx | 36 (10.5) | 45 (13.2) | 44 (12.9) | 0.068 | | N0 | 45 (13.2) | 29 (8.5) | 39 (11.4) | | N1–N3 | 37 (10.8) | 41 (12) | 24 (22) |
| | TNM (%) | | | | | | I | 26 (7.6) | 27 (7.9) | 28 (8.2) | 0.879 | | II | 51 (15.0) | 48 (14.1) | 45 (13.2) | | III | 33 (9.7) | 34 (10) | 26 (7.6) | | IV | 6 (1.7) | 2 (0.5) | 5 (1.47) |
| | Tumor grade | | | | | | G1 | 23 (19.2) | 16 (14.2) | 17 (15.9) | 0.900 | | G2 | 52 (43.3) | 49 (43.4) | 51 (47.7) | | G3 | 29 (24.2) | 28 (24.8) | 24 (22.4) |
| | Estrogen receptor status | | | | | | Positive | 85 (70.8) | 86 (76.1) | 80 (74.8) | 0.635 | | Negative | 35 (29.2) | 27 (23.9) | 27 (25.2) |
| | Progesterone receptor status | | | | | | Positive | 70 (58.3) | 73 (64.6) | 71 (66.4) | 0.415 | | Negative | 50 (41.7) | 40 (35.4) | 36 (33.6) |
| | HER2 status, (%) | | | | | | Negative | 83 (70.3) | 86 (74.8) | 83 (77.6) | 0.632 | | Positive | 29 (24.6) | 24 (20.9) | 22 (20.6) | | Unknown | 6 (5.1) | 5 (4.3) | 2 (1.9) |
| | Molecular subtype (IHC4) | | | | | | Luminal A | 46 (38.3) | 34 (30.1) | 46 (43.0) | 0.287 | | Luminal B, HER 2− | 20 (16.7) | 36 (31.9) | 21 (19.6) | | Luminal B, HER 2+ | 19 (15.8) | 15 (13.3) | 13 (12.1) | | Her2-enriched | 11 (9.2) | 7 (6.2) | 9 (8.4) | | Triple negative | 18 (15.0) | 17 (15.0) | 16 (15.0) |
|
|
